Stella Mook

PO-0905: (Semi-)Automatic contouring strategies for rectal boost treatment on the MR-Linac

Bas W Raaymakers, Gijsbert H. Bol, C. N. Nomden, 2017 .

Technical feasibility of magnetic resonance fingerprinting on a 1.5T MRI-linac.

Tom Bruijnen, Jan J W Lagendijk, Rob H N Tijssen, 2020, Physics in medicine and biology.

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

Marc Buyse, Stella Mook, Jan Bogaerts, 2006, Nature Clinical Practice Oncology.

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer

Carlos Caldas, Andrew E Teschendorff, Fabien Reyal, 2008, Breast Cancer Research.

Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Stella Mook, Fatima Cardoso, S. Mook, 2007, Cancer genomics & proteomics.

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

Michael Hauptmann, Stella Mook, L. J. Veer, 2010, Breast Cancer Research and Treatment.

Adaptive radiotherapy: The Elekta Unity MR-linac concept

Rob H.N. Tijssen, Bas W. Raaymakers, Stella Mook, 2019, Clinical and translational radiation oncology.